M

Metys Pharmaceuticals

2 employees

Metys Pharmaceuticals is developing MP-101 to prevent and treat chemotherapy-induced peripheral neuropathy.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Medical Device
Medical
Pharmaceutical
Drug development

Date founded

2013

Funding rounds raised

Total raised

$82K

from 1 investors over 1 rounds

M

Metys Pharmaceuticals raised $82K on January 1, 2019

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ